News & Articles
Selected Filters:
New clues point to a protective shield that could change harmless bacteria into killers
The research helps shed light on genes responsible for a shield-like capsule that could help protect some bacteria from our immune system, making them deadly
RoosterBio collaborates with Sartorius to expand cell and gene therapy manufacturing platform technology into South Korea
The partnership launches RoosterBio’s first international platform with off-the-shelf working cell banks and hMSC bioprocess media products in Asia
HALIX signs agreement with AstraZeneca for commercial manufacture of COVID-19 vaccine
HALIX to provide large-scale GMP manufacture of AZD1222
Pfizer/BioNTech’s COVID-19 vaccine gets a major endorsement from FDA committee
In a 17-4 vote, the FDA vaccine advisory committee recommended that Pfizer/BioNTech’s COVID-19 vaccine should be distributed to the U.S.
Orgenesis, Cure Therapeutics to advance point-of-care development and commercialization of cell and gene therapies
Parties to collaborate on development, commercialization, and supply of the Orgenesis therapies pipeline
Innovative, unbreakable & leak-proof PET media bottles
Here’s what you should know when choosing the best bottles for your cell culture experiment
Twist, Biotia introduce new NGS-based SARS-CoV-2 assay for research use
The assay is developed for use in detection, characterisation, and monitoring of the SARS-CoV-2 virus
Beckman Coulter launches its semi-quantitative SARS-CoV-2 IgG II antibody test
Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection
AstraZeneca COVID-19 vaccine AZD1222 met primary efficacy endpoint
Two different dosing regimens demonstrated efficacy with one showing a better profile
PerkinElmer launches new HPLC, UHPLC and next-generation software solution
LC 300 platform and SimplicityChrom software offers improved workflows, intuitive user interface and 21 CFR Part 11 compliance
The University of Oxford and Thermo Fisher Scientific ramp up COVID-19 testing capability
The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic
Lonza announces broad selection of high-resolution HLA-typed primary cell lots to support biologic drug research
The new lots further enhance Lonza’s renowned human primary cell offerings as it looks to meet growing market demand for deeper cell characterization
World-class speaker lineup announced for Virtual Biopharmaceutical Summit 2020
Join scientists from across the globe to explore the latest developments in biopharma, from new research techniques to cutting-edge technologies and resources to advance your work
QIAGEN launches portable digital SARS-CoV-2 antigen test that can accurately analyze over 30 samples per hour
QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes
Medicago and GSK announce start of Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate
Phase 3 part of clinical trial to enrol over 30,000 volunteers worldwide
Beckman Coulter launches its Access SARS-CoV-2 IgM assay in countries accepting the CE mark
The new IgM antibody test demonstrated 99.9% specificity with 1,400 negative samples and 100% sensitivity at >18 days post symptom onset and post positive PCR
Study shows high blood pressure and its drug treatment unlikely to increase entry of COVID-19 virus into cells
Study by University of Manchester reassures patients that it is safe to take blood pressure medication during the pandemic
PerkinElmer introduces no-wash immunoassay to help drive neuroscience disease research forward
New kit aims to provide highly sensitive and efficient approach for studying mitophagy impairment in conditions such as Parkinson’s and Alzheimer’s
Leveraging technology in quality control: The power of partnership
Marcelo Shigueru Kamei shares how the latest chromatography solutions help his team at Cristália laboratory stay a step ahead as they manufacture quality pharma products
Merck’s new VirusExpress platform speeds development of cell and gene therapies
Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies
FDA approves Gilead's antiviral remdesivir drug for treatment of COVID-19
Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days
Study shows novel mass screening method could slash COVID-19 testing costs
The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts